Association between age and synchronous liver metastasis in female colorectal cancer patients
- PMID: 21120666
- PMCID: PMC11828074
- DOI: 10.1007/s00432-010-0962-0
Association between age and synchronous liver metastasis in female colorectal cancer patients
Abstract
Purpose: The purpose of this study is to investigate the relationship between age and synchronous liver metastasis in female colorectal cancer patients.
Method: Clinical and pathological data from 655 consecutive female patients who were treated in Qilu Hospital from January 2000 to January 2010 were reviewed. First, the patients were divided into two groups: 60 years or younger and 61 years or older. A chi-square test was adopted to analyse the difference in clinicopathological characteristics between the two groups. Then, they were classified into two groups according to liver metastasis. Univariate analysis and logistic multivariate regression analysis were adopted to discriminate risk factors of liver metastasis.
Results: The chi-square test demonstrated that significant difference existed between the younger and the older groups in terms of liver metastasis (P < 0.001), lymph node metastasis (P < 0.001), tumour localization (P < 0.001), tumour invasion depth (P < 0.001), type of tumour (P < 0.001), tumour cell differentiation (P < 0.001) and venous invasion (P < 0.001). Univariate analysis demonstrated that seven factors are associated with liver metastasis. Logistic regression analysis indicated that age (P = 0.005), tumour size (P < 0.001), tumour invasion depth (P = 0.001), tumour cell differentiation (P = 0.029) and type of tumour (P < 0.001) are independent risk factors of liver metastasis.
Conclusions: The liver metastatic potential of colorectal cancer may be different between younger and older female patients. Age may independently influence liver metastasis in female colorectal cancer patients.
Conflict of interest statement
All authors have no competing interest to declare.
Similar articles
-
Tumour deposit count is an independent prognostic factor in colorectal cancer-a population-based cohort study.Br J Surg. 2024 Dec 24;112(1):znae309. doi: 10.1093/bjs/znae309. Br J Surg. 2024. PMID: 39787029 Free PMC article.
-
Histopathological evaluation of the efficacy of carbon nanoparticle staining in detecting lymph node metastasis in colorectal cancer surgery.Sci Rep. 2025 Jul 1;15(1):21619. doi: 10.1038/s41598-025-04621-0. Sci Rep. 2025. PMID: 40594272 Free PMC article.
-
Construction of a prediction model for peripheral lymph node metastasis in patients with colorectal cancer based on enhanced CT texture features.World J Surg Oncol. 2025 Jul 7;23(1):266. doi: 10.1186/s12957-025-03928-6. World J Surg Oncol. 2025. PMID: 40624517 Free PMC article.
-
Contrast-enhanced ultrasound using SonoVue® (sulphur hexafluoride microbubbles) compared with contrast-enhanced computed tomography and contrast-enhanced magnetic resonance imaging for the characterisation of focal liver lesions and detection of liver metastases: a systematic review and cost-effectiveness analysis.Health Technol Assess. 2013 Apr;17(16):1-243. doi: 10.3310/hta17160. Health Technol Assess. 2013. PMID: 23611316 Free PMC article.
-
Microwave coagulation for liver metastases.Cochrane Database Syst Rev. 2013 Oct 13;(10):CD010163. doi: 10.1002/14651858.CD010163.pub2. Cochrane Database Syst Rev. 2013. Update in: Cochrane Database Syst Rev. 2024 Mar 27;3:CD010163. doi: 10.1002/14651858.CD010163.pub3. PMID: 24122576 Updated.
Cited by
-
Clinical practice guidelines for the management of metastatic colorectal cancer: a consensus statement of the Hellenic Society of Medical Oncologists (HeSMO).Ann Gastroenterol. 2016 Oct-Dec;29(4):390-416. doi: 10.20524/aog.2016.0050. Epub 2016 Jun 3. Ann Gastroenterol. 2016. PMID: 27708505 Free PMC article.
References
-
- Adachi Y, Inomata M, Kakisako K, Sato K, Shiraishi N, Kitano S et al (1999) Histopathologic characteristics of colorectal cancer with liver metastasis. Dis Colon Rectum 42:1053–1056 - PubMed
-
- Barozzi C, Ravaioli M, D’Errico A, Grazi GL, Poggioli G, Cavrini G et al (2002) Relevance of biologic markers in colorectal carcinoma: a comparative study of a broad panel. Cancer 94:647–657 - PubMed
-
- Chen Z, Li M, Yuan Y, Wang Q, Yan L, Gu J et al (2010) Cancer/testis antigens and clinical risk factors for liver metastasis of colorectal cancer: a predictive panel. Dis Colon Rectum 53:31–38 - PubMed
-
- de Haas RJ, Wicherts DA, Salloum C, Andreani P, Sotirov D, Adam R et al (2010) Long-term outcomes after hepatic resection for colorectal metastases in young patients. Cancer 116:647–658 - PubMed
-
- De Jong KP, Stellema R, Karrenbeld A, Koudstaal J, Gouw AS, Sluiter WJ et al (1998) Clinical relevance of transforming growth factor alpha, epidermal growth factor receptor, p53, and Ki67 in colorectal liver metastases and corresponding primary tumors. Hepatology 28:971–979 - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical